In fact, it was shown that colon cancer cell lines contain cancer stem cell populations that can be enriched by the use of an in vitro, Matrigel-based differentiation assay together with selection for the expression of CD44 and CD24 cell surface markers. The gene discussed is CD44; the disease is colonic neoplasm.